Skip to main content

Advertisement

Table 2 Clinicopathologic characteristics of 63 metastatic colorectal cancer (mCRC) patients with BRAF V600E mutation

From: Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study

Characteristic No. of patients (%)
Gender
 Male 27 (42.9)
 Female 36 (57.1)
ECOG PS
 0 47 (74.6)
 1 10 (15.9)
 2 6 (9.5)
Primary tumor
 Right-sided colon 27 (42.9)
 Left-sided colon 19 (30.2)
 Rectum 17 (26.9)
No. of involved organs
 1 17 (27.0)
 > 1 46 (73.0)
Liver metastasis
 Yes 29 (46.0)
 No 34 (54.0)
Peritoneal metastasis
 Yes 26 (41.3)
 No 37 (58.7)
Distant lymph node metastasis
 Yes 50 (79.4)
 No 13 (20.6)
Lung metastasis
 Yes 12 (19.0)
 No 51 (81.0)
Mucinous or signet-ring cell component
 Yes 13 (20.6)
 No 50 (79.4)
Differentiation (adenocarcinoma)a
Well-moderate 31 (51.7)
Poor 29 (48.3)
  1. ECOG PS Eastern Cooperative Oncology Group performance status
  2. aThree cases were pure signet-ring cell carcinomas or mucinous carcinomas and were excluded here